PMD Device Solutions
7.55 SEK -5.03%Be the first to follow this company
PMD Device Solutions develops and sells medical products for respiratory monitoring for both the hospital and homecare setting. Its primary product is RespiraSense, a solution used for monitoring respiratory rate to support the detection of patient deterioration and to avoid preventable respiratory failure and adverse patient outcomes. RespiraSense is commercialised in Europe, the UK, and FDA cleared in the US.
Revenue
28.62M
EBIT %
-70.02 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
PMDS
Daily low / high price
7.55 / 8.2
SEK
Market cap
157.41M SEK
Turnover
191.79K SEK
Volume
24K
Financial calendar
Interim report
2024-05-28
General meeting
2024-05-29
Interim report
2024-08-22
Interim report
2024-11-22
Annual report
2025-02-26
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Corespring New Technology AB | 37.4 % | 37.4 % |
PharmaResearch Products | 12.3 % | 12.3 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
NOTICE OF ANNUAL GENERAL MEETING IN PMD DEVICE SOLUTIONS AB (PUBL)
PMD Device Solutions publishes 2023 Annual report
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools